AX-202
AX-202 is a human monoclonal antibody (mAb) targeting S100A4. AX-202 has antifibrotic effects in the mouse Tsk-1 model. AX-202 can be used in Plaque psoriasis and Systemic scleroderma research[1].
Product Specifications
UNSPSC
12352203
Target
Myosin
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
98.76
Smiles
[AX-202]
References & Citations
[1]Tomčík M, et al. Op0245 anti-S100A4 monoclonal antibody treatment ameliorates skin fibrosis in inflammatory and non-inflammatory pre-clinical models of systemic sclerosis[J]. 2021.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1191676-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized oxidoreductase yjdA (yjdA)
Ask
View Details 
MBS1191676-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized oxidoreductase yjdA (yjdA)
Ask
View Details MBS1191676-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis Uncharacterized oxidoreductase yjdA (yjdA)
Ask
View Details MBS1191676-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis Uncharacterized oxidoreductase yjdA (yjdA)
Ask
View Details